Latest Articles

  • Predicting the Presence of Venture Capitalists on Boards of Directors
    Matt Anestis and Heather Lindsey
    The Journal of Private Equity Winter 2001, 5 (1) 13-39; DOI: https://doi.org/10.3905/jpe.2001.319998
  • Open Access
    Editor's Letter
    James E. Schrager
    The Journal of Private Equity Winter 2001, 5 (1) 1-2; DOI: https://doi.org/10.3905/jpe.2001.390929
  • Internationalization Strategies of Private Equity Firms
    Amit Dixit and Nithya Jayaraman
    The Journal of Private Equity Winter 2001, 5 (1) 40-54; DOI: https://doi.org/10.3905/jpe.2001.319999
  • New Realities in Private Equity
    Thomas H. Kieren
    The Journal of Private Equity Winter 2001, 5 (1) 74-79; DOI: https://doi.org/10.3905/jpe.2001.320002
  • Orphan Drug Act
    Patrick O'Hagan
    The Journal of Private Equity Fall 2001, 4 (4) 14-30; DOI: https://doi.org/10.3905/jpe.2001.319993
  • Against All Odds
    Marc-Oliver Fiedler and Thomas Hellmann
    The Journal of Private Equity Fall 2001, 4 (4) 31-45; DOI: https://doi.org/10.3905/jpe.2001.319994
  • Private Equity as an Asset Class
    R. McFall. Lamm and Tanya E. Ghaleb-Harter
    The Journal of Private Equity Fall 2001, 4 (4) 68-79; DOI: https://doi.org/10.3905/jpe.2001.319996
  • Open Access
    Editor's Letter
    James E. Schrager
    The Journal of Private Equity Fall 2001, 4 (4) 1-2; DOI: https://doi.org/10.3905/jpe.2001.390915
  • Risks and Rewards in Biotech Investing
    Vera Kallmeyer and Marc Canabou
    The Journal of Private Equity Fall 2001, 4 (4) 6-13; DOI: https://doi.org/10.3905/jpe.2001.319992
  • The Venture Capital and Private Equity Industry in Brazil
    Gonzalo Checa, Ernesto Leme and Claudio Schreier
    The Journal of Private Equity Fall 2001, 4 (4) 46-67; DOI: https://doi.org/10.3905/jpe.2001.319995

Pages